Related Experiment Video
Updated: Jul 14, 2026

03:37
Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
Published on: July 5, 2024
Timosaponin B-II improves memory and learning dysfunction induced by cerebral ischemia in rats
Tie-Jun Li1, Yan Qiu, Peng-Yuan Yang
1Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
Neuroscience Letters
|June 15, 2007
Summary
Timosaponin B-II (TB-II), a compound from Anemarrhena asphodeloides, improved learning and memory in rats with vascular dementia. This neuroprotective effect may stem from TB-II's anti-inflammatory properties.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Sapogenins from Anemarrhena asphodeloides are known to enhance cognitive functions.
- Vascular dementia (VD) is a debilitating condition characterized by cognitive decline.
Purpose of the Study:
- To investigate the neuroprotective effects of Timosaponin B-II (TB-II) on learning and memory deficits in a rat model of vascular dementia.
- To explore the potential anti-inflammatory mechanisms underlying TB-II's effects.
Main Methods:
- Vascular dementia was induced in rats via transient middle cerebral artery occlusion.
- Learning and memory were assessed using the water maze and passive avoidance tasks.
- Interleukin-10 (an anti-inflammatory cytokine) and its receptor expression were measured in brain tissue.
Main Results:
- Daily oral administration of TB-II (100 and 200 mg/kg) significantly improved learning and memory deficits in VD rats.
- TB-II treatment shortened escape latency in the water maze and reversed retention deficits in the passive avoidance task.
- TB-II significantly increased the expression of interleukin-10 and its receptor in VD rats, suggesting an anti-inflammatory role.
Conclusions:
- Timosaponin B-II demonstrates significant neuroprotective effects in a rat model of vascular dementia.
- The anti-dementia effects of TB-II are, at least partly, attributed to its anti-inflammatory properties.
- TB-II represents a potential therapeutic agent for vascular dementia.
